In conversation with...
The Lancet Oncology
Subscribe
Editors at the journal and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.
Available episodes
Newest first
Oldest first
Jan 3, 2023
Sameer Bakhshi on sex disparities in childhood cancer in India
Prof Sameer Bakhshi, (All India Institute of Medical Sciences, New Delhi, India) discusses his Article on sex disparities in childhood cancer in India.
Read the full article:
Sex disparity in childhood cancer in India: a multi-centre, individual patient data analysis
playlist_add
Nov 28, 2022
Shankar Siva on radiotherapy for primary renal cell carcinoma
Shankar Siva (Peter MacCallum Cancer Centre, Melbourne, Australia) discusses his Article on 5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma.
Read the full article:
5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma
playlist_add
Nov 15, 2022
Mark Lawler and Richard Sullivan on the European Groundshot
Mark Lawler (Queen’s University Belfast, Belfast, UK) and Richard Sullivan (Kings College London, London, UK) discuss the European Groundshot—addressing Europe’s cancer research challenges: a Lancet Oncology Commission.
playlist_add
Oct 31, 2022
Samar Alhomoud on challenges for cancer control in the Gulf region
Samar Alhomoud (King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia) discusses her review on progress and remaining challenges for cancer control in the Gulf Cooperation Council.
Read the full article:
Progress and remaining challenges for cancer control in the Gulf Cooperation Council
playlist_add
Sep 27, 2022
Inge Marie Svane on mRNA vaccines for cancer treatment
Inge Marie Svane (Copenhagen University Hospital, Copenhagen, Denmark) discusses her Review on clinical advances and ongoing trials on mRNA vaccines for cancer treatment.
Read the full Review:
Clinical advances and ongoing trials on mRNA vaccines for cancer treatment
playlist_add
Aug 30, 2022
Eline Giraud and Elise Smolders on QT interval prolongation potential of anticancer
Eline Giraud and Elise Smolders from the (Radboud University Medical Center, Nijmegen, Netherlands) discuss their Review on QT interval prolongation potential of anticancer and supportive drugs.
Read the full Review:
The QT interval prolongation potential of anticancer and supportive drugs: a comprehensive overview
playlist_add
Jul 25, 2022
Ignace Vergote and Maria Kyrgiou on gynaecological cancers
Ignace Vergote (Belgium and Luxembourg Gynaecological Oncology Group, Leuven, Belgium) and Maria Kyrgiou (Imperial College London, London, UK) discuss their Series papers on gynaecological cancers.
Visit the Series hub:
Gynaecological cancers
playlist_add
Jun 30, 2022
David J Pinato on SARS-CoV-2 omicron outcomes among patients with cancer
David J Pinato (Imperial College London, London, UK) discusses the OnCovid registry study on the outcomes of the SARS-CoV-2 omicron variant outbreak among patients with cancer in Europe.
Read the full article:
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe
playlist_add
May 9, 2022
Wilfred Ngwa, Beatrice Wiafe-Addai, and David Kerr on cancer in sub-Saharan Africa
Wilfred Ngwa (Harvard Medical School, Boston, MA, USA; Johns Hopkins University, Baltimore, MD, USA; ICT University, Yaounde, Cameroon), Beatrice Wiafe-Addai (Peace and Love Hospital, Kumasi, Ghana), and David Kerr (University of Oxford, Oxford, UK) discuss the Lancet Oncology Commission on cancer in sub-Saharan Africa.
playlist_add
Apr 28, 2022
Georgios Lyratzopoulos on emergency presentation
Georgios Lyratzopoulos (Institute of Epidemiology & Health Care at University College London, London, UK) discusses his population-based study on risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission.
Read the full article:
Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation)
playlist_add
Mar 29, 2022
Lisa Iezzoni on disabilities and cancer, and Jordan Marchak on mental health problems in young cancer survivors
Lisa Iezzoni (Massachusetts General Hospital, Boston, MA, USA) discusses her Series paper on disabilities and cancer and Jordan Marchak (Children’s Healthcare of Atlanta, Atlanta, GA, USA) discusses her Review on surveillance of mental health problems in childhood, adolescent, and young adult cancer survivors.
Read the full articles:
Cancer detection, diagnosis, and treatment for adults with disabilities
Recommendations for the surveillance of mental health problems in childhood, adolescent, and young adult cancer survivors
playlist_add
Feb 28, 2022
Rosie Bradley on early-stage breast cancer treatment
Rosie Bradley (Oxford Population Health, University of Oxford, Oxford, UK) discusses her Article on aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression.
Read the full article:
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression
playlist_add
Feb 1, 2022
Yi-Long Wu and Caicun Zhou on non-small-cell lung cancer
Prof Yi-Long Wu (Guangdong Lung Cancer Institute, Guangzhou, China) and Prof Caicun Zhou (Shanghai Pulmonary Hospital, Shanghai, China) discuss the GEMSTONE 301 and GEMSTONE 302 trials on sugemalimab versus placebo in non-small-cell lung cancer.
Read the full articles:
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301)
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302)
playlist_add
Jan 31, 2022
Rebecca Fitzgerald on Barrett's oesophagus surveillance
Rebecca Fitzgerald (University of Cambridge, Cambridge, UK) discusses her Article on the use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance.
Read the full article:
Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance
playlist_add
Dec 29, 2021
Elysia Alvarez on adolescent and young adult cancer
Elysia Alvarez (UC Davis Comprehensive Cancer Center, Sacramento, USA) discusses her Article on the analysis of the global burden of adolescent and young adult cancer in 2019.
Read the full article:
The global burden of adolescent and young adult cancer in 2019
playlist_add
Nov 29, 2021
Aju Mathew on cancer care in India
Aju Mathew (Malankara Orthodox Syrian Church Medical College and Hospital, Kerala, India) discusses his Review on financial toxicity in cancer care in India.
Read the full article:
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00468-X/fulltext
playlist_add
Nov 4, 2021
David Pinato on cancer patients who recovered from SARS-CoV-2 infection
David Pinato (Imperial College London, Hammersmith Hospital, London, UK) discusses his Article on prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection.
Read the full paper: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00573-8/fulltext
playlist_add
Nov 1, 2021
James Glasbey on the effect of lockdowns on cancer surgery
James Glasbey (UK NIHR Global Health Research Unit on Global Surgery, University of Birmingham, Birmingham, UK) discusses his Article on the effect of COVID-19 pandemic lockdowns on planned cancer surgery.
Read the full paper:
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00493-9/fulltext
playlist_add
Sep 27, 2021
Manju Sengar and Christopher Booth on essential cancer drugs
Manju Sengar (Tata Memorial Centre, India) and Christopher Booth (Queen’s University Cancer Research Institute, Canada) discuss their Article on the comparison between cancer drugs deemed essential by oncologists and those included in the WHO Essential Medicines List.
Read the full paper:
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00463-0/fulltext
playlist_add
Aug 31, 2021
Susannah Stanway, Richard Cowan, Danielle Rodin, and Miriam Mutebi on helping with cancer control in LMICs
Susannah Stanway (UK Global Cancer Network), Richard Cowan (Christie NHS Foundation Trust, UK), Danielle Rodin (Princess Margaret Cancer Centre, Canada), and Miriam Mutebi (Aga Khan University Hospital, Kenya) discuss the Global Cancer Control Networks Series on how high-income countries, particularly the UK and Canada, can help with cancer control in low-income and middle-income countries.
Read the full paper:
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00374-0/fulltext
playlist_add
Jul 30, 2021
Harriet Rumgay on the burden of cancer attributable to alcohol
Harriet Rumgay (International Agency for Research on Cancer, France) discusses the recent global burden of cancer in 2020 attributable to alcohol consumption study.
Read the full paper:
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00279-5/fulltext
playlist_add
Jun 28, 2021
Rafael Cardoso and Hermann Brenner on colorectal cancer
Rafael Cardoso and Hermann Brenner (German Cancer Research Center, Heidelberg, Germany) discuss their recent paper on colorectal cancer incidence, mortality, and stage distribution in Europe.
Read the full paper:
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00199-6/fulltext
playlist_add
Jun 1, 2021
Takayuki Yoshino on the DESTINY-CRC01 trial
Takayuki Yoshino (National Cancer Center Hospital East, Kashiwa, Japan) discusses the DESTINY-CRC01 trial on trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer.
Read the full article:
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00086-3/fulltext
playlist_add
Apr 28, 2021
Roberto Orecchia on the ELIOT trial
Roberto Orecchia (European Institute of Oncology IRCCS) discusses the ELIOT trial on intraoperative irradiation for early breast cancer.
Read the full article:
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00080-2/fulltext
playlist_add
Mar 31, 2021
Hedvig Hricak, Andrew Scott, Rifat Atun, and May Abdel-Wahab on nuclear medicine
Hedvig Hricak (Memorial Sloan Kettering Cancer Center), Andrew Scott (Olivia Newton-John Cancer Research Institute), Rifat Atun (Harvard TH Chan School of Public Health), and May Abdel-Wahab (International Atomic Energy Agency) discuss the latest Lancet Oncology’s Commission on Medical Imaging and Nuclear Medicine.
Read the full article:
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30751-8/fulltext
playlist_add
Mar 1, 2021
Ariana Znaor on breast and cervical cancer in the former Soviet Union
Ariana Znaor, International Agency for Research on Cancer, discusses her Article on breast and cervical cancers stage distributions in ten newly independent states of the former Soviet Union.
Read the full article:
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30674-4/fulltext
playlist_add
Jan 21, 2021
Sathira Perera on global cancer surgery
Sathira Perera (University of New South Wales, Australia) discusses his (and colleagues) Articles on the global use of cancer surgery.
Read the full article:
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30675-6/fulltext
playlist_add
Jan 3, 2021
Short-course radiotherapy for advanced rectal cancer
Geke Hospers (University Medical Center Groningen, The Netherlands) discusses the RAPIDO trial Article published in The Lancet Oncology.
playlist_add
Nov 16, 2020
The crucial role of oncology nurses in cancer care
Annie Young (University of Warwick, UK) and Julia Challinor (University of California San Francisco, USA) present their two-paper Series on Oncology Nursing.
playlist_add
Nov 2, 2020
The effect of climate change on cancer control
Robert Hiatt (University of California San Francisco, USA) discusses his and Naomi Beyeler’s (same University) Review on climate change and cancer.
playlist_add
Sep 29, 2020
Adjuvant radiotherapy versus early salvage radiotherapy in prostate cancer
Paul Sargos (Institut Bergonié, France) discusses the GETUG-AFU 17 trial and Andrew Kneebone (Royal North Shore Hospital and University of Sidney, Australia) the RAVES trial.
playlist_add
Sep 5, 2020
Peptide receptor radionuclide therapy for neuroendocrine tumours
Lisa Bodei (Memorial Sloan Kettering Cancer Center, New York, NY, USA) discusses the Review in The Lancet Oncology on molecular profiling of neuroendocrine tumours to predict response to peptide receptor radionuclide therapy.
playlist_add
Apr 7, 2020
Larotrectinib in patients with TRK fusion-positive solid tumours
Alexander Drilon (Memorial Sloan Kettering Cancer Center, New York, NY, USA) discusses a pooled analysis in The Lancet Oncology on the role of larotrectinib in patients with TRK fusion-positive solid tumours.
playlist_add
Mar 11, 2020
The future of radiotheranostics
Ken Herrman (University Hospital Essen, Essen, Germany) discusses a Review in The Lancet Oncology on the role of injectable radiopharmaceuticals with anti-tumour effects.
playlist_add
Mar 3, 2020
International standards for the analysis of patient-reported outcomes in cancer trials
Corneel Coens and Madeline Pe discuss recommendations from the SISAQOL Consortium for the analysis of patient-reported outcomes, published in a Policy Review in The Lancet Oncology.
playlist_add
Jan 9, 2020
Presenting symptoms of cancer and stage at diagnosis
Monica Koo (University College London, London, UK) discusses an Article in The Lancet Oncology on presenting symptoms of cancer and stage at diagnosis in patients in England.
playlist_add
Dec 4, 2019
Global public and philanthropic investment in childhood cancer research
Rifat Atun (Harvard T H Chan School of Public Health, Harvard University, Boston, MA, USA) discusses a Review in The Lancet Oncology on global patterns in public and philanthropic funding for childhood cancer research with Senior Editor Márcia Costa.
playlist_add
Oct 30, 2019
Cervical cancer in India
Partha Basu (International Agency for Research on Cancer, Lyon, France) discusses a Policy Review in The Lancet Oncology on cervical cancer prevention efforts in India.
playlist_add
Oct 3, 2019
Oropharyngeal squamous cell carcinoma
David Palma and Anthony Nichols discuss the findings from their ORATOR trial on radiotherapy or robotic surgery for oropharyngeal squamous cell carcinoma.
playlist_add
Sep 3, 2019
Cancer in small island nations
New Zealand’s new interim Cancer Control Agency director, Diana Sarfati, discusses a series of five papers exploring cancer control in small island nations.
playlist_add
Aug 29, 2019
Advances in radioimmunotherapy
Eric Deutsch (Gustave Roussy Comprehensive Cancer Center, Villejuif, France) presents The Lancet Oncology’s latest series on advances in radioimmunotherapy for cancer.
playlist_add
Jul 2, 2019
International Neoadjuvant Melanoma Consortium
Georgina Long (The University of Sydney, Sydney, NSW, Australia) discusses three papers from The Lancet Oncology on neoadjuvant approaches for melanoma treatment.
playlist_add
May 29, 2019
IMWG consensus on imaging in plasma cell disorders
Jens Hillengass discusses the new International Myeloma Working Group consensus guidelines on optimal use of imaging methods for monoclonal plasma cell disorders.
playlist_add
May 15, 2019
Digital oncology
Kee Yuan Ngiam (National University Hospital Singapore, Singapore) discusses a duo of papers exploring big data and machine-learning algorithms for healthcare delivery and pathology in oncology.
playlist_add
Apr 2, 2019
Choosing Wisely India
CS Pramesh discusses ten low-value or harmful practises that should be avoided in cancer care in India.
playlist_add
Mar 5, 2019
Paediatric vertebral radiotherapy
Bianca Hoeben discusses the latest guidelines from the SIOPE radiotherapy working group on vertebral radiotherapy dose in paediatric patients.
playlist_add
Feb 2, 2019
Malignant plural mesothelioma
Anna Bibby joins The Lancet Oncology to discuss recent developments in the treament of malignant plural mesothelioma.
playlist_add
Jan 3, 2019
CAR T-cell therapy
Frederick Locke joins The Lancet Oncology to discuss long-term results from the ZUMA-1 trial on the safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma.
playlist_add
Nov 29, 2018
Cervical cancer screening in older women
Talía Malagón discusses her modelling study which assesses the age at which to stop cervical cancer screening in older women and the remaining lifetime risk of cervical cancer.
playlist_add
Oct 19, 2018
Palliative care in oncology
Stein Kaasa and Jon Loge discuss their new Commission on palliative care.
playlist_add
Sep 27, 2018
Global review of cancer control
Andre Ilbawi talks about his global analysis of available national cancer control plans with The Lancet Oncology.
playlist_add
Aug 31, 2018
Are patient reported outcomes consistent?
A review in The Lancet Oncology asks whether patient reported outcomes in RCTs are consistent across their analysis, reporting, and interpretation. Author Madeline Pe discusses the findings.
playlist_add
Aug 31, 2018
Changing incidence of adolescent cancer
Eva Steliarova-Foucher joins The Lancet Oncology to discuss the Europe-wide Automated Childhood Cancer Information System, and the increase in cancer incidence rates among children and adolescents.
playlist_add
Aug 14, 2018
Diffuse intrinsic pontine glioma
Mark Souweidane joins The Lancet Oncology to discuss his dose-escalation study, assessing a convection-enhanced delivery for diffuse intrinsic pontine glioma.
playlist_add
Jun 30, 2018
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer
Bo Jan Noordman joins The Lancet Oncology to discuss the findings from his study of residual disease detection in oesophageal cancer.
playlist_add
Jun 1, 2018
Gender and cancer immunotherapy efficacy
Fabio Conforti talks to The Lancet Oncology about a meta-analysis showing that a patient's sex can affect the efficacy of cancer immunotherapy.
playlist_add
Apr 25, 2018
PROs in regulatory decision making
Paul Kluetz from the US FDA discusses the issues surrounding the use of patient-reported outcomes in regulatory decision making.
playlist_add
Mar 29, 2018
Vulvar field resection
Michael Hoeckel joins The Lancet Oncology to discuss his latest trial on the surgical treatment of vulvar carcinoma based on the theory of ontogenetic cancer fields.
playlist_add
Mar 1, 2018
Chromatin organisation and cancer prognosis
Håvard Emil Danielsen joins The Lancet Oncology to discuss his latest paper on machine learning algorithms to analyse chromatin organisation as a prognostic marker for cancer.
playlist_add
Dec 30, 2017
Trial design for brain metastases: The Lancet Oncology: Jan 2018
Ross Camidge discusses RANO's papers on clinical trial design for patients with brain metastases.
playlist_add
Nov 28, 2017
Lung cancer screening: The Lancet Oncology: November 27, 2017
John Field discusses a European position statement on lung cancer screening using low-dose CT.
playlist_add
Nov 1, 2017
Future cancer research priorities in the USA: The Lancet Oncology Commission: October 31, 2017
Commission co-chairs Chi Van Dang and Elizabeth M. Jaffee discuss a new Lancet Oncology Commission on cancer treatment and care in the USA.
playlist_add
Sep 28, 2017
Cancer in Peru: The Lancet Oncology
Ben Anderson talks about cancer care and cancer trends in Peru.
playlist_add
Sep 2, 2017
Selective internal radiotherapy for colorectal cancer: The Lancet Oncology: September 2017
Ricky Sharma discusses results from three prospective trials on the use of selective internal radiotherapy for liver metastases from colorectal cancer.
playlist_add
Jul 26, 2017
Indel derived tumour-specific neoantigens: The Lancet Oncology: Aug 2017
Samra Turajlic discusses the contribution of small insertions and deletions to tumour-specific antigen analyses.
playlist_add
Jun 29, 2017
Prior radiotherapy and pembrolizumab: The Lancet Oncology: June 28, 2017
Percy Lee discusses the impact of prior radiotherapy on the efficacy of pembrolizumab when used to treat non-small cell lung cancer.
playlist_add
Jun 3, 2017
EANO and palliative care: The Lancet Oncology: June 2, 2017
Martin Taphoorn outlines the importance of palliative care for patients with gliomas.
playlist_add
Apr 26, 2017
Head and neck cancer Series: The Lancet Oncology: April 26, 2017
Sandro Porceddu discusses the new Lancet Oncology Series on head and neck cancer.
playlist_add
Mar 30, 2017
18F-FDG PET/CT for multiple myeloma: The Lancet Oncology: April, 2017
Michele Cavo discusses the International Myeloma Working Group’s recommendations on the use of 18F-FDG PET/CT for patients with multiple myeloma and other plasma cell dyscrasias.
playlist_add
Mar 2, 2017
Response assessment criteria for immunotherapy drugs: The Lancet Oncology: March 2017
Lesley Seymour discusses the iRECIST guidelines for assessing tumour responses in immunotherapy trials.
playlist_add
Feb 2, 2017
Genomic modelling for radiation dosage: The Lancet Oncology: Feb 1 2017
Javier Torres-Roca and Louis Harrison join us to discuss their work on genome modelling and its uses in calculating the appropriate radiation dosage.
playlist_add
Dec 30, 2016
Cancer survivorship in the USA: The Lancet Oncology: 30 December
Ann Partridge talks about cancer survival in the USA.
playlist_add
Nov 5, 2016
Non-small cell lung cancer: The Lancet Oncology and The Lancet Respiratory Medicine: November 4, 2016
Rafael Rossell discusses RET inhibitors and non-small cell lung cancer.
playlist_add
Oct 31, 2016
Quality of life and low-grade glioma: The Lancet Oncology: 31 October, 2016
Brigitta Baumert discusses her article on quality of life in patients with high-risk, low-grade glioma.
playlist_add
Sep 1, 2016
Renal surveillance: The Lancet Oncology: August 30, 2016
Brian Rini discusses active surveillance for patients with metastatic renal cell carcinoma.
playlist_add
Jul 27, 2016
Multiple myeloma: The Lancet Oncology: July 26, 2016
Shaji Kumar discusses updated consensus criteria from the International Myeloma Working Group for response and minimal residual disease assessment in multiple myeloma.
playlist_add
Jun 30, 2016
HPV vaccination in Japan: The Lancet Oncology: June 28, 2016
Catherine Sauvaget and Ryo Konno discuss Japan’s low uptake of screening programmes for breast and cervical cancer.
playlist_add
Jun 2, 2016
Antibody-drug conjugates for cancer therapy: The Lancet Oncology: June 01, 2016
Anish Thomas discusses use of antibody-drug conjugates for cancer therapy.
playlist_add
Apr 27, 2016
Ethical issues in paediatric oncology trials: The Lancet Oncology: April 26, 2016
Jean-Claude Dupont and François Doz discuss ethical issues in paediatric oncology clinical trials.
playlist_add
Mar 12, 2016
Medulloblastoma: The Lancet Oncology: March 11, 2016
Michael Taylor discusses treatment approaches to the rare brain tumour that generally affects children, medulloblastoma.
playlist_add
Feb 11, 2016
NAB-paclitaxel and breast cancer: The Lancet Oncology: February 8, 2016
Sibylle Loibl discusses the findings and clinical implications of the GeparSepto trial.
playlist_add
Feb 3, 2016
Rare cancers: The Lancet Oncology | February 2, 2016
Dr. Richard Carvajal discusses aspects of treatment and research for rare cancers.
playlist_add
Dec 24, 2015
Mantle-cell lymphoma: The Lancet Oncology: January 2016
Discussion of two new treatment approaches to indolent lymphoma and mantle-cell lymphoma, haematological diseases with generally poor response to chemotherapy.
playlist_add
Nov 2, 2015
Neuro-oncology: The Lancet Oncology, November 2015
Hideho Okada discusses immunotherapy response assessment criteria in neuro-oncology.
playlist_add
Sep 10, 2015
Metastatic breast cancer: The Lancet Oncology: Sept 10, 2015
Rajendra Badwe discusses treatment options for metastatic breast cancer.
playlist_add
Aug 11, 2015
Breast cancer: The Lancet Oncology: Aug 6, 2015
Harry Bear discusses the use of adjuvant and neoadjuvant bevacizumab in the treatment of early breast cancer.
playlist_add
Jul 7, 2015
Watchful waiting for patients with rectal cancer: The Lancet Oncology: July 6, 2015
Ane Appelt discusses adopting a watchful waiting approach for patients with rectal cancer who achieved a clinical complete response after chemoradiotherapy.
playlist_add
Jun 10, 2015
HPV vaccine dosing schedules: The Lancet Oncology: June 10, 2015
Amy Kreimer discusses HPV vaccine dosing schedules and cervical cancer prevention.
playlist_add
May 28, 2015
RANO Group: The Lancet Oncology: May 28, 2015
Nancy Lin discusses RANO Group’s new response assessment criteria checklist.
playlist_add
Apr 30, 2015
HPV and cancer: The Lancet Oncology: April 30, 2015
Rolando Herrero summarises three papers that constitute the HPV and cancer Series.
playlist_add
Mar 18, 2015
Advances in cancer drug development: The Lancet Oncology: March 18, 2015
Jeffery Weber discuses advances in cancer drug development.
playlist_add
Mar 2, 2015
The Lancet Oncology: March 02, 2015
Dr Saro Armenian discusses long term health concerns for survivors of childhood cancers.
playlist_add
Jan 17, 2015
The Lancet Oncology: January 16, 2015
Jeff Bradley discusses standard verses high-dose radiation in conjunction with chemotherapy for patients with phase III non-small-cell lung cancer.
playlist_add
Dec 16, 2014
The Lancet Oncology: December 16, 2014
Dennis Slamon discusses advances in breast cancer treatment based on data from the PALOMA trial.
playlist_add
Nov 24, 2014
The Lancet Oncology: November 24, 2014
Charles Bennett discusses the development and regulatory landscape of biosimilar oncology drugs.
playlist_add
Oct 27, 2014
The Lancet Oncology: October 27, 2014
S Vincent Rajkumar of the Mayo Clinic discusses the updated disease definition of multiple myeloma.
playlist_add
Sep 17, 2014
The Lancet Oncology: September 17, 2014
Daniel M Green discusses the effect of treatment for childhood cancers on male fertility.
playlist_add
Aug 28, 2014
The Lancet Oncology: August 28, 2014
Naomi Lee discusses new research about depression and cancer with Michael Sharpe and Jane Walker.
playlist_add
Jul 7, 2014
The Lancet Oncology: July 07, 2014
Robert Hills discusses a meta-analysis of gemtuzumab ozogamicin for the treatment of adult myeloid leukaemia.
playlist_add
Jun 30, 2014
The Lancet Oncology: June 30, 2014
Jeremy Whelan from the National Cancer Research Institute discusses the underrepresentation of teenagers and young adults in clinical cancer trials.
playlist_add
May 27, 2014
The Lancet Oncology: May 27, 2014
Paul Spiegel discusses cancer in refugees in Jordan and Syria and how the UNHCR have addressed the provision of expensive cancer treatment.
playlist_add
May 5, 2014
The Lancet Oncology: May 05, 2014
Laura Essermann discusses cancer over-diagnosis and over-treatment.
playlist_add
May 2, 2014
The Lancet Oncology: May 02, 2014
Ian Krop discusses a phase III trial to assess efficacy of trastuzumab emtansine for women with recurrent HER2-positive breast cancer.
playlist_add
Mar 19, 2014
The Lancet Oncology: March 19, 2014
Michael Höckel joins Natalie Harrison to discuss how surgery based on ontogenetic staging is sufficient to control cervical cancer without additional radiotherapy.
playlist_add
Feb 7, 2014
The Lancet Oncology: February 07, 2014
Christopher Klenk and Heike E Daldrup-Link join Natalie Harrison to discuss ionising radiation-free techniques in cancer detection.
playlist_add
Jan 14, 2014
The Lancet Oncology: January 14, 2014
Jonathan Banks discusses the aims and implications of a study into public preferences for cancer testing.
playlist_add
Dec 5, 2013
The Lancet Oncology: December 05, 2013
Roberta de Angelis discusses the results and implications of the EUROCARE 5 study
playlist_add
Nov 11, 2013
The Lancet Oncology: November 11, 2013
Jayant Vaidya and Umberto Veronesi discuss the TARGIT and ELIOT trials of intraoperative radiotherapy for early breast cancer
playlist_add
Oct 14, 2013
The Lancet Oncology: October 14, 2013
Ramon Luengo-Fernandez discusses the cost of cancer care in the European Union.
playlist_add
Sep 2, 2013
The Lancet Oncology: September 02, 2013
Jesus San Miguel discusses a phase 3 trial comparing pomalidomide plus low-dose dexamethasone with high-dose dexamethasone in patients with multiple myeloma.
playlist_add
Jul 10, 2013
The Lancet Oncology: July 10, 2013
Ole Raaschou-Nielsen discusses the association between long-term exposure to ambient air pollution and lung cancer risk.
playlist_add
Jun 7, 2013
The Lancet Oncology: June 07, 2013
Perry Pickhardt discusses the value of CT colonography to determine whether small colorectal polyps will progress or not.
playlist_add
May 15, 2013
The Lancet Oncology: May 15, 2013
Thorsten Kuehn discusses the SENTINA study, concerning centinel lymph node biopsy before and after neoadjuvant chemotherapy in breast cancer.
playlist_add
Apr 26, 2013
The Lancet Oncology: April 26, 2013
Paul Goss presents an overview of The Lancet Oncology Commission on cancer prevention in Latin America.
playlist_add
Apr 16, 2013
The Lancet Oncology: April 16, 2013
Yael Mosse discusses a phase I study about the potential of targeted molecular therapy for childhood cancers.
playlist_add
Apr 3, 2013
The Lancet Oncology: April 03, 2013
Sulma Mohammed discusses a pilot study of breast cancer screening in rural Sudan.
playlist_add
Feb 20, 2013
The Lancet Oncology: February 20, 2013
Kathy Pritchard-Jones discusses a Series about paediatric oncology.
playlist_add
Jan 25, 2013
The Lancet Oncology: January 25, 2013
John Farley discusses a trial of the MEK inhibitor selumetinib for the treatement of low-grade serous carcinoma of the ovary and peritoneum.
playlist_add
Dec 4, 2012
The Lancet Oncology: December 04, 2012
Nicole Krekel discusses a trial which assesses ultrasound-guided breast conserving surgery in the management of breast cancer.
playlist_add
Nov 14, 2012
The Lancet Oncology: November 14, 2012
Anticancer drugs: doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours.
playlist_add
Oct 30, 2012
The Lancet Oncology: October 30, 2012
Asian Oncology Summit: Consensus guidelines on palliative care, kidney cancer, and colorectal cancer.
playlist_add
Aug 23, 2012
The Lancet Oncology: August 23, 2012
Discussion of a UK/French study into adult diabetes risk after radiation for childhood cancer.
playlist_add
Aug 6, 2012
The Lancet Oncology: August 06, 2012
Gustavo Ismael discusses subcutaneous versus intravenous administration of trastuzumab in patients with breast cancer.
playlist_add
Jul 13, 2012
The Lancet Oncology: July 13, 2012
Discussion of the oral MEK inhibitor trametinib in cancer treatment. .
playlist_add
Jun 6, 2012
The Lancet Oncology: June 06, 2012
Circulating tumour cells as a possible prognostic marker for non-metastatic breast cancer.
playlist_add
May 1, 2012
The Lancet Oncology: May 01, 2012
Matthias Kloor discusses the prevalence of mismatch repair-deficient crypt foci in Lynch syndrome.
playlist_add
Mar 23, 2012
The Lancet Oncology: March 23, 2012
Andrew Grulich discusses his paper looking at HPV infection and anal cancer.
playlist_add
Feb 22, 2012
The Lancet Oncology: February 22, 2012
The association between endometriosis and ovarian cancer.
playlist_add
Feb 10, 2012
The Lancet Oncology: February 10, 2012
The effect of chemotherapy in pregnancy on health outcomes in young children.
playlist_add
Jan 30, 2012
The Lancet Oncology: January 30, 2012
Discussion of updated guidelines for the appropriate use of opioids in the management of cancer pain.
playlist_add
Nov 25, 2011
The Lancet Oncology: November 25, 2011
HLA matching of transplanted umbilical-cord blood for treating leukaemia and myelodysplastic syndrome.
playlist_add
Nov 14, 2011
The Lancet Oncology: November 14, 2011
Comparison of CT colonography with conventional colonoscopy for colorectal cancer screening.
playlist_add
Oct 28, 2011
The Lancet Oncology: October 28, 2011
Discussion of a promising antiangiogenic approach for the treatment of ovarian cancer, and other highlights from the November issue.
playlist_add
Sep 30, 2011
The Lancet Oncology: September 30, 2011
October highlights, including discussion of the trial about the tyrosine kinase ALK and non-small-cell lung cancer.
playlist_add
Sep 26, 2011
The Lancet Oncology: September 26, 2011
David Collingridge launches The Lancet Oncology Commission on delivering affordable cancer care in high-income countries.
playlist_add
Aug 26, 2011
The Lancet Oncology: August 26, 2011
September issue highlights, including discussion of HPV testing and cytology.
playlist_add
Jul 29, 2011
The Lancet Oncology: July 29, 2011
The role of dignity therapy in end-of-life cancer care.
playlist_add
Jun 24, 2011
The Lancet Oncology: June 24, 2011
Emma Grainger with July highlights, and an interview about a trial assessing the value of zoledronic acid in the treatment of pre-menopausal early breast cancer.
playlist_add
May 27, 2011
The Lancet Oncology: May 27, 2011
June issue highlights, including faecal blood tests to assess future colorectal cancer risk, and of the 'dangerous liaison' between cancer and tuberculosis.
playlist_add
Apr 29, 2011
The Lancet Oncology: April 29, 2011
May highlights, including discussion of a phase II study about the treatment of B-cell lymphoma in very old patients.
playlist_add
Apr 1, 2011
The Lancet Oncology: April 01, 2011
April issue highlights, including the latest developments of the breast Health Global Initiative(BHGI), including an interview with BHGI Director Benjamin Anderson.
playlist_add
Mar 1, 2011
The Lancet Oncology: March 01, 2011
March issue highlights, including new data from the HERA trial about long-term efficacy of herceptin for early breast cancer.
playlist_add
Jan 31, 2011
The Lancet Oncology: January 31, 2011
Rob Brierley with February highlights, including the prevalence of depression among cancer patients.
playlist_add
Dec 30, 2010
The Lancet Oncology: December 30, 2010
January highlights, including automated verses manual cytology for detection of cervical cancers.
playlist_add
Nov 29, 2010
The Lancet Oncology: November 29, 2010
December issue highlights, including mammography screening for younger women with familial breast cancer.
playlist_add
Nov 1, 2010
The Lancet Oncology: November 01, 2010
November issue highlights, including an large-scale HPV genotype analysis with implications for cervical-cancer vaccine development, and the potential for discontinuation of imatinib treatment for people with chronic myeloid leukaemia.
playlist_add
Oct 4, 2010
The Lancet Oncology: October 04, 2010
Includes author interview about a trial comparing sentinal-lymph-node biopsy with axillary-lymph-node dissection in breast cancer treatment.
playlist_add
Sep 1, 2010
The Lancet Oncology: September 01, 2010
September issue highlights, including discussion of a possible association between hepatitis B infection and non-Hodgkin lymphoma in a Korean population.
playlist_add
Aug 2, 2010
The Lancet Oncology: August 02, 2010
August issue highlights, including bevacizumab for NSCLC, and cancer issues among people with mental illness.
playlist_add
Jul 5, 2010
The Lancet Oncology: July 05, 2010
Roy Herbst discusses the Zodiac trial, a phase 3 study assessing the efficacy of vandetanib for treating advanced non-small-cell lung cancer.
playlist_add
Jun 1, 2010
The Lancet Oncology: June 01, 2010
Emma Grainger discusses erlotinib as maintenance treatment for lung cancer, and IGF1 and risk of breast cancer.
playlist_add
Apr 29, 2010
The Lancet Oncology: April 29, 2010
The role of zoledronic acid with chemotherapy for early breast cancer and other issue highlights are discussed.
playlist_add
Mar 29, 2010
The Lancet Oncology: March 29, 2010
April issue highlights, including a genome-wide association study of lung cancer for never smokers.
playlist_add
Mar 1, 2010
The Lancet Oncology: March 01, 2010
March issue highlights, including hypofractionated radiotherapy for early breast cancer.
playlist_add
Feb 1, 2010
The Lancet Oncology: February 01, 2010
Discussion of phase I novel targeted therapy for sarcoma.
playlist_add
Jan 6, 2010
The Lancet Oncology: January 06, 2010
Emma Grainger with issue highlights and Kathy Albain discussing chemotherapy and tamoxifen for post-menopausal women with breast cancer.
playlist_add
Dec 1, 2009
The Lancet Oncology: December 01, 2009
Audrey Ceschia discusses issue highlights, including impact of HIV infection on cancer risk.
playlist_add
Oct 29, 2009
The Lancet Oncology: October 29, 2009
Discussion of new oncology management guidelines derived from didactic workshops at the Asia Oncology Summit 2009.
playlist_add
Sep 28, 2009
The Lancet Oncology: September 28, 2009
Rob Brierley discusses an antithrombolic agent for patients receiving chemotherapy for solid tumours.
playlist_add
Aug 27, 2009
The Lancet Oncology: August 27, 2009
Discussion of prostate cancer treatment, the PASSION-P trial, and a new Quackery column.
playlist_add
Jul 29, 2009
The Lancet Oncology: July 29, 2009
Rob Brierley discusses sunitinib for kidney cancer, and how bureaucracy is stifling UK clinical research.
playlist_add
Jul 1, 2009
The Lancet Oncology: July 01, 2009
Emma Grainger discusses bariatric surgery, weight loss, and cancer risk for obese people.
playlist_add
May 28, 2009
The Lancet Oncology: May 28, 2009
Audrey Ceschia discusses issue highlights, including treatment for nausea and vomiting from chemotherapy.
playlist_add
Apr 29, 2009
The Lancet Oncology: April 29, 2009
David Collingridge discusses research articles on prophylactic cranial irradiation for small-cell lung cancer, and the addition of temozolomide to radiotherapy for treating glioblastoma.
playlist_add
Mar 30, 2009
The Lancet Oncology: March 30, 2009
Rob Brierley discusses research articles on cancer survival in England, and the potential for ovarian cancer screening.
playlist_add
Mar 5, 2009
The Lancet Oncology: March 05, 2009
Emma Grainger discusses articles on myelodysplastic syndromes, circulating tumour cells and prostate cancer, and palliative stents for oesophageal cancer.
playlist_add
Jan 30, 2009
The Lancet Oncology: January 30, 2009
Rob Brierley discusses two research articles investigating genetic subtypes of childhood acute lymphoblastic leukaemia.
playlist_add
Dec 23, 2008
The Lancet Oncology: December 23, 2008
Emma Grainger discusses liver transplantation criteria, sorafenib for liver cancer in the Asia-Pacific, and NICE guidance on erlotinib for non-small-cell lung cancer.
playlist_add
Nov 26, 2008
The Lancet Oncology: November 26, 2008
David Collingridge discusses a research article comparing microsurgery with total excision for basal-cell carcinoma of the face, and other content highlights.
playlist_add
Oct 28, 2008
The Lancet Oncology: October 28, 2008
Rob Brierley introduces the latest issue, including research articles about prostate cancer and a review highlighting the importance of appropriate palliative care.
playlist_add
Oct 1, 2008
The Lancet Oncology: October 01, 2008
John Sellors and Guglielmo Ronco discuss HPV screening for precursors of cervical cancer.
playlist_add
Aug 26, 2008
The Lancet Oncology: August 26, 2008
Sally van der Meer discusses highlights from the September journal in this issue's podcast, including a new treatment option for preventing bone mineral loss among pre-menopausal women receiving hormone therapy for early breast cancer.
playlist_add
Aug 11, 2008
The Lancet Oncology: August 11, 2008
The Lancet Oncology podcast - a global health theme for the August issue. Editor David Collingridge discusses the highlights, including cancer survival from five continents, and a review of cancer issues in Africa.
playlist_add
Jun 30, 2008
The Lancet Oncology: June 30, 2008
TLO Editor David Collingridge discusses some highlights from the July issue: radiofrequency ablation showing promise for the treatment of lung cancer; how a rare form of obesity could negatively affect treatment outcomes; and a discussion of a recent meeting at IARC in Lyon, France, concerning the latest evidence on smoke-free policies and the effects on public health.
playlist_add
Jun 9, 2008
The Lancet Oncology: June 09, 2008
Emma Cannell and Sally van der Meer discuss highlights from the June issue: a prospective pilot study assessing the role of stellate-ganglion block to treat hot flushes in survivors of breast cancer; also discussed is a Personal View about cancer of unknown primary (CUP), and the Leading Edge on public confidence in Merck's HPV vaccine.
playlist_add
Apr 30, 2008
The Lancet Oncology: April 30, 2008
Editor David Collingridge discusses highlights from the May issue: the natural history of cervical intraepithelial neoplasia; the effect of screening on prostate-cancer mortality in the USA and UK; and the launch of a series of reviews about cancer in indigenous populations, starting this month with cancer among indigenous Polynesians.
playlist_add
Mar 26, 2008
The Lancet Oncology: March 26, 2008
Editor David Collingridge discusses highlights from the April issue including: encouraging results from the START trials suggest fewer fractions of radiotherapy could revolutionise treatment of early stage breast cancer; how a phase II study investigating yttrium-90 labelled ibritumomab could have an important future role in the treatment of follicular non-Hodgkin lymphoma, and finally the pressing need for increased recruitment of adolescents and young adults in to cancer trials.
playlist_add
Feb 25, 2008
The Lancet Oncology: February 25, 2008
Dr David Collingridge, Editor of the Lancet Oncology, discusses highlights of the March issue in the first Lancet Oncology podcast. Two main topics are discussed: a research article highlighting how individuals in the United States who are under-insured or who have no medical insurance are at an increased risk of presenting with late-stage cancers; non-whites are at a similarly increased cancer risk. Also featured is a Dutch study showing the potential benefits of a shared-care programme between family doctors and oncology clinics for the long-term follow-up of individuals diagnosed with cancer in childhood.
playlist_add